{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:01:16Z","timestamp":1783778476027,"version":"3.55.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006489","name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006489","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.cbi.2023.110488","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T23:50:57Z","timestamp":1681257057000},"page":"110488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Chelation therapy with 3,4,3-Li(1,2-HOPO) after pulmonary exposure to plutonium in rats"],"prefix":"10.1016","volume":"378","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8129-9168","authenticated-orcid":false,"given":"Olivier","family":"Gr\u00e9my","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Devilliers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Miccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2023.110488_bib1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1051\/radiopro:2008047","article-title":"Autorisation de mise sur le march\u00e9 du Ca-DTPA","volume":"43","author":"Grappin","year":"2008","journal-title":"Radioprotection"},{"key":"10.1016\/j.cbi.2023.110488_bib2","first-page":"1","article-title":"Guidebook for the treatment of accidental internal radionuclide contamination workers","volume":"41","author":"Bhattacharyya","year":"1992","journal-title":"Radiat. Protect. Dosim."},{"key":"10.1016\/j.cbi.2023.110488_bib3","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.2174\/138920112802273308","article-title":"Calcium and zinc DTPA administration for internal contamination with plutonium-238 and americium-241","volume":"13","author":"Kazzi","year":"2012","journal-title":"Curr. Pharmaceut. Biotechnol."},{"key":"10.1016\/j.cbi.2023.110488_bib4","first-page":"53984","article-title":"Guidance for industry on pentetate calcium trisodium and pentetate zinc trisodium for treatment of internal contamination with plutonium, americium, or curium, Federal Register","volume":"68","year":"2003","journal-title":"Notices"},{"key":"10.1016\/j.cbi.2023.110488_bib5","series-title":"Base de donn\u00e9es publique des m\u00e9dicaments","year":"2018"},{"key":"10.1016\/j.cbi.2023.110488_bib6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.HP.0000326345.41816.c2","article-title":"The quest for therapeutic actinide chelators","volume":"95","author":"Durbin","year":"2008","journal-title":"Health Phys."},{"key":"10.1016\/j.cbi.2023.110488_bib7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/oxfordjournals.rpd.a032445","article-title":"Development of decorporation agents for the actinides","volume":"79","author":"Durbin","year":"1998","journal-title":"Radiat. Protect. Dosim."},{"key":"10.1016\/j.cbi.2023.110488_bib8","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1021\/cr990114x","article-title":"Rational design of sequestering agents for plutonium and other actinides","volume":"103","author":"Gorden","year":"2003","journal-title":"Chem. Rev."},{"key":"10.1016\/j.cbi.2023.110488_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1021\/jm00396a005","article-title":"Specific sequestering agents for the actinides. 16. Synthesis and initial biological testing of polydentate oxohydroxypyridinecarboxylate ligands","volume":"31","author":"White","year":"1988","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2023.110488_bib10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/rpd\/26.1-4.351","article-title":"Removal of Pu-238(IV) from mice by poly-catechoylate, poly-hydroxamate or poly-hydroxypyridinonate ligands","volume":"26","author":"Durbin","year":"1989","journal-title":"Radiat. Protect. Dosim."},{"key":"10.1016\/j.cbi.2023.110488_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/095530000138853","article-title":"Multidentate hydroxypyridinonate ligands for Pu(IV) chelation in vivo: comparative efficacy and toxicity in mouse of ligands containing 1,2-HOPO or Me-3,2-HOPO","volume":"76","author":"Durbin","year":"2000","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.cbi.2023.110488_bib12","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1021\/jm010564t","article-title":"Synthesis and initial evaluation for in vivo chelation of Pu(IV) of a mixed octadentate spermine-based ligand containing 4-carbamoyl-3-hydroxy-1-methyl-2(1H)-pyridinone and 6-carbamoyl-1-hydroxy-2(1H)-pyridinone","volume":"45","author":"Xu","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2023.110488_bib13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/HP.0b013e3181c21273","article-title":"Biomimetic actinide chelators: an update on the preclinical development of the orally active hydroxypyridonate decorporation agents 3,4,3-LI(1,2-HOPO) and 5-LIO(Me-3,2-HOPO)","volume":"99","author":"Abergel","year":"2010","journal-title":"Health Phys."},{"key":"10.1016\/j.cbi.2023.110488_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ddr.21020","article-title":"Significance of single variables in defining adequate animal models to assess the efficacy of new radionuclide decorporation agents: using the contamination dose as an example","volume":"73","author":"Jarvis","year":"2012","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.cbi.2023.110488_bib15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1667\/RR3115.1","article-title":"Dose-dependent efficacy and safety toxicology of hydroxypyridinonate actinide decorporation agents in rodents: towards a safe and effective human dosing regimen","volume":"179","author":"Bunin","year":"2013","journal-title":"Radiat. Res."},{"key":"10.1016\/j.cbi.2023.110488_bib16","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/09553009314552191","article-title":"Early chelation therapy for injected Pu-238 and Am-241 in the rat: comparison of 3,4,3-LIHOPO, DFO-HOPO, DTPA-DX, DTPA and DFOA","volume":"63","author":"Volf","year":"1993","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.cbi.2023.110488_bib17","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3109\/09553002.2014.925150","article-title":"238Pu elimination profiles after delayed treatment with 3,4,3LI(1,2HOPO) in female and male Swiss-Webster mice","volume":"90","author":"An","year":"2014","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.cbi.2023.110488_bib18","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cbi.2016.03.034","article-title":"From early prophylaxis to delayed treatment: establishing the plutonium decorporation activity window of hydroxypyridinonate chelating agents","volume":"267","author":"An","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2023.110488_bib19","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/095530096144653","article-title":"Chelation therapy by DFO-HOPO and 3,4,3-LIHOPO for injected Pu-238 and Am-241 in the rat: effect of dosage, time and mode of chelate administration","volume":"70","author":"Volf","year":"1996","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.cbi.2023.110488_bib20","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/oxfordjournals.rpd.a006292","article-title":"Octadentate hydroxypyridinonate (HOPO) ligands for plutonium (i.v.): pharmacokinetics and oral efficacy","volume":"105","author":"Durbin","year":"2003","journal-title":"Radiat. Protect. Dosim."},{"key":"10.1016\/j.cbi.2023.110488_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/09553009314551191","article-title":"Comparative efficacies of 3,4,3-LIHOPO and DTPA for enhancing the excretion of plutonium and americium from the rat after simulated wound contamination as nitrates","volume":"64","author":"Stradling","year":"1993","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.cbi.2023.110488_bib22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/rpd\/53.1-4.319","article-title":"Removal of plutonium and americium from the rat using 3,4,3-LIHOPO and DTPA after simulated wound contamination : effect of delayed administration and mass of plutonium","volume":"53","author":"Gray","year":"1994","journal-title":"Radiat. Protect. Dosim."},{"key":"10.1016\/j.cbi.2023.110488_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/095530096145382","article-title":"Treatment with 3,4,3-LIHOPO of simulated wounds contaminated with plutonium and americium in rat","volume":"70","author":"Volf","year":"1996","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.cbi.2023.110488_bib24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/09553009514551671","article-title":"Efficacy of 3,4,3-LIHOPO for enhancing the excretion of plutonium from rat after simulated wound contamination as a tributyl-n-phosphate complex","volume":"68","author":"Paquet","year":"1995","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.cbi.2023.110488_bib25","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/09553009214552381","article-title":"The efficacies of 3,4,3-LIHOPO and DTPA for enhancing the excretion of plutonium and americium from the rat: comparison with other siderophore analogues","volume":"62","author":"Stradling","year":"1992","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.cbi.2023.110488_bib26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/09553009314551611","article-title":"Efficacy of 3,4,3-LIHOPO for reducing the retention of 238Pu in rat after inhalation of the tributyl phosphate complex","volume":"64","author":"Poncy","year":"1993","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.cbi.2023.110488_bib27","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/rpd\/53.1-4.323","article-title":"Reduction of the retention of Pu-238 inhaled as the tributylphosphate complex in rats treated by 3,4,3-LiHOPO","volume":"53","author":"Paquet","year":"1994","journal-title":"Radiat. Protect. Dosim."},{"key":"10.1016\/j.cbi.2023.110488_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4103\/0972-0464.101682","article-title":"Radioanalytical determination of plutonium and americium using ion exchange and extraction chromatography technique in urine","volume":"24","author":"Santhanakrishnan","year":"2011","journal-title":"Radiat. Protect. Environ."},{"key":"10.1016\/j.cbi.2023.110488_bib29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1088\/0952-4746\/30\/1\/001","article-title":"Absorption of plutonium compounds in the respiratory tract","volume":"30","author":"Davesne","year":"2010","journal-title":"J. Radiol. Prot."},{"key":"10.1016\/j.cbi.2023.110488_bib30","series-title":"The Chemistry of the Actinide and Transactinide Elements","first-page":"3339","article-title":"Actinides in animals and man","author":"Durbin","year":"2006"},{"key":"10.1016\/j.cbi.2023.110488_bib31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1667\/RR2866.1","article-title":"Decorporation approach following rat lung contamination with a moderately soluble compound of plutonium using local and systemic Ca-DTPA combined chelation","volume":"178","author":"Gr\u00e9my","year":"2012","journal-title":"Radiat. Res."},{"key":"10.1016\/j.cbi.2023.110488_bib32","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1667\/RR15451.1","article-title":"Chelation treatment by early inhalation of liquid aerosol DTPA for removing plutonium after rat lung contamination","volume":"192","author":"Miccoli","year":"2019","journal-title":"Radiat. Res."},{"key":"10.1016\/j.cbi.2023.110488_bib33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/09553009114552491","article-title":"Microdistribution of 239Pu in the rat skeleton. Part I. Dose dependency","volume":"60","author":"Sontag","year":"1991","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.cbi.2023.110488_bib34","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3109\/03630269.2011.560771","article-title":"Multidentate terephthalamidate and hydroxypyridonate ligands: towards new orally active chelators","volume":"35","author":"Abergel","year":"2011","journal-title":"Hemoglobin"},{"key":"10.1016\/j.cbi.2023.110488_bib35","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/oxfordjournals.rpd.a006296","article-title":"Efficacy of 3,4,3-LI(1,2-HOPO) for decorporation of Pu, Am and U from rats injected intramuscularly with high-fired particles of MOX","volume":"105","author":"Paquet","year":"2003","journal-title":"Radiat. Protect. Dosim."},{"key":"10.1016\/j.cbi.2023.110488_bib36","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/00004032-197206000-00030","article-title":"Plutonium deposition kinetics in the rat","volume":"22","author":"Durbin","year":"1972","journal-title":"Health Phys."},{"key":"10.1016\/j.cbi.2023.110488_bib37","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.crci.2007.01.015","article-title":"Review of actinide decorporation with chelating agents","volume":"10","author":"Ansoborlo","year":"2007","journal-title":"C. R. Chimie"},{"key":"10.1016\/j.cbi.2023.110488_bib38","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1038\/s41467-019-10240-x","article-title":"Ultra-selective ligand-driven separation of strategic actinides","volume":"10","author":"Deblonde","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cbi.2023.110488_bib39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/ddr.21246","article-title":"Biodistribution of the multidentate hydroxypyridinonate ligand [14C]-3,4,3-LI(1,2-HOPO), a potent actinide decorporation agent","volume":"76","author":"Choi","year":"2015","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.cbi.2023.110488_bib40","series-title":"Diagnoses and Treatment of Incorporated Radionuclides","first-page":"387","article-title":"The experimental use of aerosol and liposomal forms of Ca-DTPA as a treatment for plutonium contamination","author":"Stather","year":"1976"},{"key":"10.1016\/j.cbi.2023.110488_bib41","first-page":"387","article-title":"The use of Puchel and DTPA for removing 238PuO2 from the lungs of hamsters","volume":"41","author":"Stradling","year":"1981","journal-title":"Health Phys."},{"key":"10.1016\/j.cbi.2023.110488_bib42","first-page":"919","article-title":"Decorporation of inhaled plutonium nitrate from hamsters using Zn-DTPA","volume":"46","author":"Stradling","year":"1984","journal-title":"Health Phys."},{"key":"10.1016\/j.cbi.2023.110488_bib43","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1177\/096032718500400603","article-title":"Use of DTPA for increasing the rate of elimination of plutonium-238 and americium-241 from rodents after their inhalation as the nitrates","volume":"4","author":"Stather","year":"1985","journal-title":"Hum. Toxicol."},{"key":"10.1016\/j.cbi.2023.110488_bib44","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1667\/RR2203.1","article-title":"Preferential decorporation of americium by pulmonary administration of DTPA dry powder after inhalation of aged PuO2 containing americium in rats","volume":"174","author":"Gr\u00e9my","year":"2010","journal-title":"Radiat. Res."},{"key":"10.1016\/j.cbi.2023.110488_bib45","first-page":"72","article-title":"Plasma proteins of the bronchoalveolar surface of the lungs of smokers and nonsmokers","volume":"124","author":"Bell","year":"1981","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.cbi.2023.110488_bib46","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1113\/jphysiol.2005.103465","article-title":"Alveolar type I cells protect rat lung epithelium from oxidative injury","volume":"572","author":"Chen","year":"2006","journal-title":"J. Physiol."},{"key":"10.1016\/j.cbi.2023.110488_bib47","first-page":"520","article-title":"Decorporation of 238PuO2 from the hamster by inhalation of chelating agents","volume":"42","author":"Stather","year":"1982","journal-title":"Health Phys."},{"key":"10.1016\/j.cbi.2023.110488_bib48","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2307\/3574969","article-title":"Toward an optimal DTPA therapy for decorporation of actinides: time-dose relationships for plutonium in the dog. I","volume":"78","author":"Guilmette","year":"1979","journal-title":"Radiat. Res."},{"key":"10.1016\/j.cbi.2023.110488_bib49","doi-asserted-by":"crossref","first-page":"448","DOI":"10.2307\/3574971","article-title":"Dependency of chelation efficacy upon time after first DTPA injection","volume":"78","author":"Lloyd","year":"1979","journal-title":"Radiat. Res."},{"key":"10.1016\/j.cbi.2023.110488_bib50","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1667\/RR14193.1","article-title":"Decorporation of Pu\/Am actinides by chelation therapy: new arguments in favor of an intracellular component of DTPA action","volume":"185","author":"Gr\u00e9my","year":"2016","journal-title":"Radiat. Res."},{"key":"10.1016\/j.cbi.2023.110488_bib51","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1269\/jrr.11112","article-title":"Plutonium behavior after pulmonary administration according to solubility properties, and consequences on alveolar macrophage activation","volume":"53","author":"Van der Meeren","year":"2012","journal-title":"J. Radiat. Res."},{"key":"10.1016\/j.cbi.2023.110488_bib52","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/09553000400005486","article-title":"Comparative tissue uptake and cellular deposition of three different plutonium chemical forms in rats","volume":"80","author":"Fouillit","year":"2004","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.cbi.2023.110488_bib53","series-title":"Proceedings of a EULEP Symposium on Bone and Bone Seeking Radionuclides: Physiology, Dosimetry and Effects","first-page":"39","article-title":"Plutonium in bone: the effects of bone remodelling","author":"Volf","year":"1981"},{"key":"10.1016\/j.cbi.2023.110488_bib54","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1667\/RR14782.1","article-title":"Decorporation approach after rat lung contamination with plutonium: evaluation of the key parameters influencing the efficacy of a protracted chelation treatment","volume":"188","author":"Gr\u00e9my","year":"2017","journal-title":"Radiat. Res."},{"key":"10.1016\/j.cbi.2023.110488_bib55","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/15376516.2012.728641","article-title":"Actinide chelation: biodistribution and in vivo complex stability of the targeted metal ions","volume":"23","author":"Kullgren","year":"2013","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.cbi.2023.110488_bib56","first-page":"5295","article-title":"Efficient discrimination of transplutonium actinides by in vivo models","volume":"12","author":"Pallares","year":"2021","journal-title":"Chem"},{"key":"10.1016\/j.cbi.2023.110488_bib57","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/rpd\/53.1-4.315","article-title":"Comparative toxicity of 3,4,3-LiHOPO and DTPA in baboons - preliminary-results","volume":"53","author":"Fritsch","year":"1994","journal-title":"Radiat. Protect. Dosim."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279723001552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279723001552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T20:36:52Z","timestamp":1736368612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279723001552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":57,"alternative-id":["S0009279723001552"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2023.110488","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chelation therapy with 3,4,3-Li(1,2-HOPO) after pulmonary exposure to plutonium in rats","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2023.110488","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110488"}}